According to the report “Tumor Ablation Market”, published by Market Data Forecast, the global market is projected to reach USD 681.79 million by 2021, at a CAGR of 12.7% from 2016 to 2021

For full report refer to “”

Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver. Rising Prevalence of cancer is proportional to the growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.

Free sample for the report is available at “”

Growing geriatric population across the globe, increasing number of people affected with cancer, technological advancements in the field of ablation are the major driving factors for the global tumor ablation market. However therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to increase in gestation period of product launches are hindering the growth of the market.

Request Customization “”

Global Tumor Ablation Market is segmented

By Technology
•Radiofrequency Ablation Devices,
•Microwave Ablation Devices,
•Cryoablation Devices and
•other Ablation Devices

By Treatment
•Surgical Ablation,
•Laparoscopic Ablation and
•Percutaneous Ablation

By Application
•Liver Cancer,
•Breast Cancer,
•Lung Cancer,
•Prostrate Metastasis and
•other cancer

By Geography
•North America
•Latin America
•Middle-East & Africa

Enquire more about the report at “”

Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.

Buy now “”